Open AccessAcute generalised exanthematous pustulosis following intravitreal Ranibizumab
Author(s) -
Bosanquet David C,
Davies Wendy L,
May Kenneth,
Harding Keith G,
Patel Girish K
Publication year - 2011
Publication title -
international wound journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.867
H-Index - 63
eISSN - 1742-481X
pISSN - 1742-4801
DOI - 10.1111/j.1742-481x.2011.00799.x
Subject(s) - acute generalized exanthematous pustulosis , medicine , ranibizumab , dermatology , antibiotics , ophthalmology , surgery , bevacizumab , chemotherapy , microbiology and biotechnology , biology
Acute generalised exanthematous pustulosis, or AGEP, is a well documented cutaneous drug reaction. It typically occurs within 48 hours of oral antibiotics, but can be caused by other medications and, occasionally, after viral infections. We present a case of AGEP following intravitreal injection of Ranibizumab, a monoclonal antibody vascular endothelial growth factor inhibitor.